TrialAnnals of the rheumatic diseases2024

Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.

Di Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.